Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

Gene editing slashes cholesterol in monkey study
LDL aggregation: A modifiable marker of cardiovascular risk
3rd-generation MitraClip device approved by FDA
Docs want to inform patients about cost—but don’t have the time or tools
FDA approves less-invasive LVAD implant procedure
QFR method could expand access to physiological stenosis assessment
Medication management program ineffective for curbing hypertension
Mitochondrial transplants may revive damaged heart cells
Red Cross seeks blood donations after summer shortage
Blacks have worse long-term survival after in-hospital cardiac arrest